Classification of Epstein-Bair vims-associated posttransplant lymphoproliferative diseases: Implications for understanding their pathogenesis and developing rational treatment strategies
Hanto DW. Classification of Epstein-Bair vims-associated posttransplant lymphoproliferative diseases: implications for understanding their pathogenesis and developing rational treatment strategies. Annu Rev Med 1995; 46:381-394
Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and the Mayo Clinic Organized International Consensus Development Meeting
Paya CV, Fung JJ, Nalesnik MA, et al. Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation 1999; 68:1517-1525
Analysis of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after lung transplantation
Montone KT, Litzky LA, Wurster A, et al. Analysis of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after lung transplantation. Surgery 1996; 119:544-551
PTLD in thoracic organ transplant recipients: Ten years of cyclosporine-based immunosuppression
Armitage JM, Kormos RL, Stuart RS, et al. PTLD in thoracic organ transplant recipients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant 1991; 10:877-887